Latest press and news

Apr 23

Press Releases Regulatory

Teckningskursen för utnyttjande av teckningsoptioner av serie TO1 i 2cureX AB har fastställts till 13,22 SEK och teckningsperioden inleds den 26 april 2021

Apr 23

Press Releases Regulatory

The exercise price for the warrants of series TO1 in 2cureX AB has been determined to SEK 13.22 and the subscription period starts April 26, 2021

Mar 1

Press ReleasesPress Releases Regulatory

2cureX announces that the clinical trial of IndiTreat®-guided treatment of metastatic colorectal cancer has met the primary endpoint.

Feb 25

Press Releases Regulatory

2cureX publishes year-end report for 2020.

Feb 4

Press ReleasesPress Releases Regulatory

IndiTreat® selected to prestigious multinational ovarian cancer project.

Jan 28

Press ReleasesPress Releases Regulatory

2cureX appoints Kenneth Graabek Johansen, an experienced business and financial executive, as new CFO.

Jan 5

Press ReleasesPress Releases Regulatory

2cureX appoints Fernando Andreu, an international Biotech executive, as new CEO

Nov 26

Press Releases Regulatory

2cureX publishes interim report for the third quarter of 2020.